August 4, 2015 — Triple therapy is no better than dual antiplatelet therapy in preventing major adverse cardiac events ...
EP Lab
This channel includes news and new technology innovations for cardiac electrophysiology (EP) systems, techniques and devices using in EP labs. This includes implantable EP devices, pacemakers, implantable cardioverter defibrillators (ICD), cardiac resychronization therapy (CRT), ablation technologies, left atrial appendage (LAA) occlusion, atrial fibrilation (AF) and Holter monitors.
August 3, 2015 — Biotronik announced CE approval of 3 Tesla (T) magnetic resonance imaging (MRI) scanning with exclusion ...
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...
July 28, 2015 — Biotronik announced the first patients have been successfully implanted with Itrevia HF-T QP cardiac ...
Apple created a stir when it announced in 2018 that its Apple Watch Series 4 was the first consumer health and fitness ...
July 22, 2015 — Heart failure patients had a significantly lower chance of being readmitted within 30 days of discharge ...
July 20, 2015 - A new study proves race and gender-related disparities exist in care for patients who have recently been ...
Washington Health System (WHS) provides healthcare services at more than 40 offsite locations across three counties in ...
July 16, 2015 - Medtronic plc announced the first in-office implant of its miniaturized cardiac monitor as part of the ...
July 13, 2015 - The U.S. Food and Drug Administration (FDA) is alerting healthcare providers and patients about reports ...
July 8, 2015 - Sorin S.p.A. and Cyberonics Inc. unveiled LivaNova as the name of their combined company, effective at ...
Apple created a stir when it announced in 2018 that its Apple Watch Series 4 was the first consumer health and fitness ...
July 7, 2015 - Biosense Webster Inc. announced the launch of the Confidense Module, an innovative technology that ...
July 7, 2015 - Results from an interim analysis of the Phase III RE-VERSE AD patient study demonstrate that 5 g of ...
July 2, 2015 - Boston Scientific has initiated a worldwide study to evaluate the rate and causes of shocks for patients ...